# Cellens

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellens

- Industry: Healthcare
- Headquarters: US
- Website: www.cellensinc.com
- Latest round: Seed (Aug 15, 2025)
- Investors on record: 1

## About

Based in Massachusetts, US, and founded in 2020 by Jonas Pirkl, and XueYing Wang, and Phuong Jean Pham (CEO), Cellens Inc. is a developer of cell fixation, sample processing, nanoimaging cell surface, and machine learning technology platform for bladder cancer detection. In January 2022, the firm raised an amount of seed funding from new investor SOSV.

Cellens Inc. brings clarity and confidence to cancer detection through advanced nanoscale imaging and machine learning. The firm is actively collaborating with cancer clinics, health care professionals, and health insurance organizations.

## Funding rounds

- Seed, Aug 15, 2025 — SOSV
- Seed, Jan 11, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed